1-8 of 8
Sule Mine Bakanay
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Return to Work after Allogeneic HSCT: Further Insights in the Patients-Related Predictive Factors (The SOPRALLO Project)

Free
Yana Stepanishyna, Sebastian Wittnebel, Fabio Andreozzi, Adriano Salaroli, Paulus Kristanto, Chloe Spilleboudt, Marie France Jaivenois, Sandra Michiels, Rezarta Ajazi, Charlotte Vandevoorde, Virginie De Wilde, Nathalie Meuleman, Philippe Lewalle, Dominique Bron, Sule Mine Bakanay Ozturk
Journal: Blood
Blood (2024) 144 (Supplement 1): 4929.
https://doi.org/10.1182/blood-2024-209736
Published: 2024
Journal Articles

Post-Induction Undetectable Minimal Residual Disease at 10 -5 Sensitivity Level within Marrow and/or Stem Cell Graft Overrides Cytogenetic High Risk

Free
Guldane Cengiz Seval, Klara Dalva, Dilek Oz, Sule Mine Bakanay, Ender Soydan, Gunhan Gurman, Osman Ilhan, Meral Beksac
Journal: Blood
Blood (2021) 138 (Supplement 1): 2909.
https://doi.org/10.1182/blood-2021-148879
Published: 2021
Journal Articles

Residual Clonal Plasma Cells Detected By Flow Cytometry at 10 -4 level within Autologous Stem Cell Grafts Is Associated with Significantly Less Overall Survival

Free
Guldane Cengiz Seval, Klara Dalva, MD, Sule Mine Bakanay, Mustafa Merter, MD, Ugur Sahin, MD, Atilla Uslu, MD, Cemaleddin Ozturk, Osman Ilhan, MD, Meral Beksac, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3438.
https://doi.org/10.1182/blood-2018-99-111794
Published: 2018
Journal Articles

Impact of PET-CT Response on Survival Parameters Following Autologous Stem Cell Transplantation Among Patients with Multiple Myeloma: Comparison of Two Cut-Off Values

Free
Meral Beksac, MD, Mehmet Gunduz, MD, Mehmet Ozen, MD, Sule Mine Bakanay Ozturk, MD, Ozlem Kucuk, MD, Elgin Ozkan, MD
Journal: Blood
Blood (2014) 124 (21): 3983.
https://doi.org/10.1182/blood.V124.21.3983.3983
Published: 2014
Journal Articles

Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers

Free
Elif Suyani, MD, Sule Mine Bakanay, MD, Klara Dalva, MD, Ezgi Cakmak, MSc, Rauf Haznedar, MD, Gulsan Sucak, MD, Meral Beksac, MD
Journal: Blood
Blood (2012) 120 (21): 4904.
https://doi.org/10.1182/blood.V120.21.4904.4904
Published: 2012
Journal Articles

Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.

Free
Sule Mine Bakanay, MD, Klara Dalva, MD, Berna Elif Koksoy, MD, Erol Ayyildiz, Muhit Ozcan, M.D., Osman Ilhan, MD, Meral Beksac, MD
Journal: Blood
Blood (2012) 120 (21): 3024.
https://doi.org/10.1182/blood.V120.21.3024.3024
Published: 2012
Journal Articles

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndrome: A Retrospective Validation From a Single Centre.

Free
Pervin Topcuoglu, MD, Klara Dalva, M.D., Sule Mine Bakanay, MD, Sinem Civriz Bozdag, M.D., Onder Arslan, M.D., Muhit Ozcan, M.D., Mutlu Arat, MD, Meral Beksac, MD, Gunhan Gurman, M.D.
Journal: Blood
Blood (2009) 114 (22): 4846.
https://doi.org/10.1182/blood.V114.22.4846.4846
Published: 2009
Journal Articles

Factors Involved in Response to Thalidomide in Myelodysplastic Syndrome: Impace of HLA and Prognostic Factors

Free
Sule Mine Bakanay, MD, Klara Dalva, MD, Pervin Topcuoglu, MD, Sinem Civriz-Bozdag, MD, Mutlu Arat, MD, Meral Beksac, MD, Gunhan Gurman, MD
Journal: Blood
Blood (2008) 112 (11): 5079.
https://doi.org/10.1182/blood.V112.11.5079.5079
Published: 2008